 SAN DIEGO, May 25, 2021 GLOBE NEWSWIRE -- TRACON Pharmaceuticals NASDAQ: TCON, a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost efficient, CRO-independent product development platform to partner with ex-U.S. companies to develop and commercialize innovative products in the U.S., today announced that Charles Theuer, M.D., Ph.D., President and Chief Executive Officer, will present a corporate overview at the Jefferies Virtual Healthcare Conference on June 4, 2021 at 2:30pm Eastern Time. 